Selective IgA Deficiency: High-Yield USMLE Review

High-yield review of selective IgA deficiency: pathophysiology, recurrent mucosal infections, transfusion reactions, diagnosis, and exam pitfalls.

Introduction

Selective IgA deficiency (SIgAD) is defined by markedly reduced or absent IgA with otherwise normal immunoglobulin isotypes, and it is widely described as the most common primary immunodeficiency. A key reason it is so testable is that many patients are *asymptomatic* until mucosal immunity is stressed, so the diagnosis often emerges through patterns rather than a dramatic single infection. (pubmed.ncbi.nlm.nih.gov)

For USMLE learners, the big idea is simple: **IgA protects mucosal surfaces**, so loss of IgA primarily shows up where mucosal defense matters most. That is why exam stems classically feature recurrent sinopulmonary infections, chronic gastrointestinal complaints, allergic disease, autoimmune associations, or an anaphylactic reaction to an IgA-containing transfusion in a patient whose IgG and IgM levels are still normal. (pubmed.ncbi.nlm.nih.gov)

Pathophysiology

The core immune defect

The central lesion in SIgAD is not loss of all B cells, but a **failure of terminal differentiation and class switching toward IgA-producing plasma cells**. In practical terms, the immune system can still make other major immunoglobulin classes, yet it does not generate adequate IgA at mucosal interfaces. (pubmed.ncbi.nlm.nih.gov)

This matters because IgA is the dominant immunoglobulin in secretions that coat mucosal surfaces. When that layer is missing, the respiratory and gastrointestinal tracts become more vulnerable to infection, antigen exposure, and immune dysregulation. That same mucosal vulnerability also helps explain why allergy and autoimmunity appear so often in the clinical story. (pubmed.ncbi.nlm.nih.gov)

Why the presentation is so variable

A classic point of confusion is that SIgAD can be both **common** and **subtle**. Reviews consistently note that many affected individuals remain healthy or minimally symptomatic, whereas others develop recurrent infections, allergic disease, autoimmune disease, or transfusion reactions; that heterogeneity is part of what makes the diagnosis easy to miss. (pubmed.ncbi.nlm.nih.gov)

For Step-style reasoning, keep the immunology framing tight: the problem is a **selective mucosal antibody defect**, not a pan-humoral collapse. If the question stem preserves IgG and IgM but repeatedly punishes the patient at mucosal sites, SIgAD should move high on the differential. (pubmed.ncbi.nlm.nih.gov)

Clinical Presentation

Most patients are either asymptomatic or discovered incidentally, but symptomatic patients usually declare themselves through **recurrent respiratory infections**. The high-yield organisms classically emphasized are *Haemophilus influenzae* and *Streptococcus pneumoniae*, with presentations such as recurrent sinusitis, otitis media, bronchitis, or pneumonia. (pubmed.ncbi.nlm.nih.gov)

Gastrointestinal disease is the next major pattern. Chronic diarrhea, *Giardia lamblia* infection, and malabsorption syndromes that can resemble celiac disease are all classic clues, especially when they occur alongside normal IgG and IgM levels. (pubmed.ncbi.nlm.nih.gov)

Immune dysregulation broadens the phenotype beyond infection. SIgAD is associated with allergic and atopic disease such as asthma, eczema, and allergic rhinitis, and it also carries increased rates of autoimmune conditions including systemic lupus erythematosus, rheumatoid arthritis, autoimmune thyroid disease, and celiac disease. (pubmed.ncbi.nlm.nih.gov)

A particularly testable complication is the **transfusion reaction**. Some patients form anti-IgA antibodies, so exposure to blood products containing IgA can trigger reactions that range from urticaria to life-threatening anaphylaxis; on exams, this clue is almost pathognomonic when paired with low IgA and otherwise preserved immunoglobulins. (pubmed.ncbi.nlm.nih.gov)

High-yield presentation patterns

Diagnostic Approach

Diagnosis starts with **quantitative immunoglobulin testing**. The classic hallmark is serum IgA below 7 mg/dL with normal IgG and IgM, which is exactly why SIgAD shows up in exam stems as “recurrent mucosal infections, but normal major antibody classes except IgA.” (pubmed.ncbi.nlm.nih.gov)

The next step is to avoid premature closure. SIgAD should be separated from *secondary* causes of low IgA and from other primary antibody disorders, and reviews also note that vaccine responses are generally preserved in the diagnostic definition even though the clinical problem remains one of mucosal defense. (pubmed.ncbi.nlm.nih.gov)

Celiac testing is a favorite board trap. Because IgA-based serologies may be falsely negative in IgA deficiency, screening should shift toward **IgG-based testing**, such as anti-tissue transglutaminase IgG, when celiac disease is suspected. (pubmed.ncbi.nlm.nih.gov)

Just as important as the lab panel is the history. If a patient with recurrent sinopulmonary or GI infections also reports a previous severe transfusion reaction, that combination should push SIgAD even higher on your list. (pubmed.ncbi.nlm.nih.gov)

A practical exam-oriented workup

  1. Quantify immunoglobulins and look for **isolated low IgA**. (pubmed.ncbi.nlm.nih.gov)
  2. Confirm that IgG and IgM are preserved rather than globally decreased. (pubmed.ncbi.nlm.nih.gov)
  3. Exclude secondary causes before labeling the disorder primary. (pubmed.ncbi.nlm.nih.gov)
  4. If celiac disease is in the differential, use **IgG-based serology** rather than relying only on IgA-based tests. (pubmed.ncbi.nlm.nih.gov)
  5. Ask directly about prior reactions to blood products. (pubmed.ncbi.nlm.nih.gov)

Management & Prevention

Management is usually **supportive rather than replacement-based**. Most patients are treated by promptly addressing bacterial infections, monitoring symptom patterns over time, and individualizing care according to infection burden and associated autoimmune or allergic disease. (pubmed.ncbi.nlm.nih.gov)

Vaccination and prevention are central. The provided source emphasizes routine immunizations, especially pneumococcal and influenza vaccines, and PubMed reviews similarly stress staying current with vaccination and considering antibiotic prophylaxis in patients with recurrent infections. (pubmed.ncbi.nlm.nih.gov)

Transfusion counseling is one of the most important practical steps. Patients with prior or suspected anti-IgA-mediated reactions should receive **IgA-poor or washed red blood cells**, and some situations may require IgA-deficient donor products or other special transfusion planning. (pubmed.ncbi.nlm.nih.gov)

Long-term follow-up matters because SIgAD is not just an “infection” diagnosis. Patients should be monitored for the later emergence of autoimmune disease, allergic disease, and in some cases evolution toward common variable immunodeficiency (CVID). (pubmed.ncbi.nlm.nih.gov)

What management is really testing on exams

High-Yield Differentials & Pitfalls

SIgAD is easiest to recognize when you contrast it with the other antibody deficiencies students commonly confuse on exams. The major distinctions are the **pattern of immunoglobulin loss**, whether **B cells are globally decreased**, and whether the phenotype points to a selective mucosal defect versus broader humoral failure. (pubmed.ncbi.nlm.nih.gov)

| Disorder | Immunoglobulin pattern | B-cell pattern | High-yield clue | |---|---|---|---| | **Selective IgA deficiency** | Low/absent IgA with normal IgG and IgM. (pubmed.ncbi.nlm.nih.gov) | Defect in switching/differentiation toward IgA rather than global B-cell absence. (pubmed.ncbi.nlm.nih.gov) | Recurrent mucosal infections, giardiasis, allergy/autoimmunity, or transfusion anaphylaxis. (pubmed.ncbi.nlm.nih.gov) | | **Bruton agammaglobulinemia** | Marked reduction/absence of all major immunoglobulin classes. (pubmed.ncbi.nlm.nih.gov) | Absent or severely reduced circulating B cells. (pubmed.ncbi.nlm.nih.gov) | Global humoral failure rather than isolated mucosal IgA loss. (pubmed.ncbi.nlm.nih.gov) | | **Common variable immunodeficiency (CVID)** | Reduced IgG with decreased IgA and sometimes IgM. (pubmed.ncbi.nlm.nih.gov) | Often normal or near-normal circulating B-cell count despite impaired antibody production. (pubmed.ncbi.nlm.nih.gov) | Recurrent sinopulmonary infections with broader symptomatic hypogammaglobulinemia; SIgAD can precede it in some patients. (pubmed.ncbi.nlm.nih.gov) |

Common pitfalls

Exam Vignette

A 21-year-old woman has had recurrent sinus infections and several episodes of otitis media since adolescence. She also reports intermittent nonbloody diarrhea. Laboratory testing shows markedly decreased serum IgA, but normal IgG and IgM. During a later transfusion for trauma, she develops hypotension, wheezing, and urticaria within minutes. (pubmed.ncbi.nlm.nih.gov)

**Most likely diagnosis:** Selective IgA deficiency. (pubmed.ncbi.nlm.nih.gov)

**Why this is the right answer:**

Key Takeaways

Keep Learning

Read this article on CoreStepPrep